Related Experiment Video
Updated: May 7, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Vitamin D in heart failure
Anna J Meredith1, Bruce M McManus
1James Hogg Research Centre, Institute for Heart and Lung Health, University of British Columbia, Vancouver, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Insights
Vitamin D deficiency is a cardiovascular risk factor, but current evidence is insufficient to recommend vitamin D supplements for preventing heart failure after heart injury.
Area of Science:
- Cardiology
- Endocrinology
- Nutritional Science
Background:
- Growing evidence links vitamin D to cardiovascular health, with deficiency identified as a significant risk factor.
- The human heart possesses vitamin D signaling pathways, suggesting a direct role in cardiac physiology and outcomes.
- Myocardial remodeling is central to heart failure (HF), a condition with increasing global impact.
Purpose of the Study:
- To critically appraise the scientific literature on vitamin D's role in cardiovascular disease.
- To review epidemiologic, supplementation, animal model, and in vitro data.
- To evaluate vitamin D's potential as a therapeutic adjunct for HF prevention.
Main Methods:
- Comprehensive review and critical appraisal of existing scientific literature.
- Analysis of epidemiologic studies, clinical supplementation trials, and preclinical research (animal models, in vitro studies).
Main Results:
- Substantial associative data link vitamin D status to cardiovascular outcomes.
- Evidence supports vitamin D's involvement in key pathogenic processes like cardiac hypertrophy and extracellular matrix remodeling.
- Limited mechanistic data exist to support vitamin D supplementation for HF prevention post-myocardial injury.
Conclusions:
- While vitamin D is associated with cardiovascular health and influences cardiac remodeling, its therapeutic role in preventing heart failure requires further mechanistic investigation.
- Current evidence does not support vitamin D supplementation as a primary strategy for preventing heart failure following myocardial injury.
Abstract:
Evidence linking vitamin D to cardiovascular (CV) health has accumulated in recent years: numerous epidemiologic studies report deficiency as a significant CV risk factor, and rodent models suggest that active vitamin D can modulate critical remodeling processes, including cardiac hypertrophy and extracellular matrix remodeling. The presence of vitamin D signaling machinery within the human heart implies a direct role for this hormone in cardiac physiology and may explain associations between vitamin D status and CV outcomes. Heart failure (HF) represents a growing social and economic burden worldwide. Myocardial remodeling is central to HF development, and in the context of emerging evidence supporting mechanistic involvement of vitamin D, this review provides critical appraisal of scientific literature related to the role of vitamin D in CV disease, including data from epidemiologic and supplementation studies, as well as novel findings from animal models and in vitro work. Although associative data linking vitamin D and CV outcomes and evidence supporting a role for vitamin D in relevant pathogenic processes are both substantial, there are limited mechanistic data to indicate vitamin D supplementation as a viable therapeutic adjunct for the prevention of HF development following myocardial injury.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Heart Failure V: Medical Management